Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Faber

Showing results (91-100 of 119) with videos related to

Pageof 12
Sort By:
Acta Medica Scandinavica|January 1, 1981
Practical clinical value of the C-peptide response to glucagon stimulation in the choice of treatment in diabetes mellitusS Madsbad, T Krarup, P McNair, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|January 1, 1996
Evaluation of the developmental neuroendocrine and reproductive toxicology of aluminiumS K Agarwal, L Ayyash, C S Gourley, et al.
Journal of Pharmaceutical and Biomedical Analysis|May 18, 2016
Validation and determination of taselisib, a β-sparing phosphoinositide 3-kinase (PI3K) inhibitor, in human plasma by LC-MS/MSX Ding, K Faber, Y Shi, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|January 1, 1982
Hormonal and metabolic changes in hepatic cirrhosisD G Johnston, K G Alberti, C Binder, et al.
Neuropediatrics|July 4, 2007
Idiopathic neuralgic amyotrophy in childhoodI Kotsopoulos, K Faber, J Raaijmakers, et al.
The Quarterly Journal of Medicine|April 1, 1979
Diurnal profiles of serum insulin, C-peptide and blood intermediary metabolites in insulin treated diabetics, their relationship to the control of diabetes and the role of endogenous insulin secretionC M Asplin, M Hartog, D J Goldie, et al.
Diabetologia|December 1, 1982
Hormonal, metabolic and cardiovascular responses to hypoglycaemia in Type 1 (insulin-dependent) diabetes with and without residual B cell functionS Madsbad, J Hilsted, T Krarup, et al.
European Journal of Clinical Investigation|February 1, 1981
Development of bone mineral loss in insulin-treated diabetes: a 1 1/2 years follow-up study in sixty patientsP McNair, C Christiansen, M S Christensen, et al.
Annals of Neurology|April 1, 1988
Aphasia in senile dementia of the Alzheimer typeK Faber-Langendoen, J C Morris, J W Knesevich, et al.
Diabetologia|November 1, 1979
Bone loss in diabetes: effects of metabolic stateP McNair, S Madsbad, C Christiansen, et al.
Pageof 12

Showing results (91-100 of 119) with videos related to

Sort By:
Pageof 12
Acta Medica Scandinavica|January 1, 1981
Practical clinical value of the C-peptide response to glucagon stimulation in the choice of treatment in diabetes mellitusS Madsbad, T Krarup, P McNair, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|January 1, 1996
Evaluation of the developmental neuroendocrine and reproductive toxicology of aluminiumS K Agarwal, L Ayyash, C S Gourley, et al.
Journal of Pharmaceutical and Biomedical Analysis|May 18, 2016
Validation and determination of taselisib, a β-sparing phosphoinositide 3-kinase (PI3K) inhibitor, in human plasma by LC-MS/MSX Ding, K Faber, Y Shi, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|January 1, 1982
Hormonal and metabolic changes in hepatic cirrhosisD G Johnston, K G Alberti, C Binder, et al.
Neuropediatrics|July 4, 2007
Idiopathic neuralgic amyotrophy in childhoodI Kotsopoulos, K Faber, J Raaijmakers, et al.
The Quarterly Journal of Medicine|April 1, 1979
Diurnal profiles of serum insulin, C-peptide and blood intermediary metabolites in insulin treated diabetics, their relationship to the control of diabetes and the role of endogenous insulin secretionC M Asplin, M Hartog, D J Goldie, et al.
Diabetologia|December 1, 1982
Hormonal, metabolic and cardiovascular responses to hypoglycaemia in Type 1 (insulin-dependent) diabetes with and without residual B cell functionS Madsbad, J Hilsted, T Krarup, et al.
European Journal of Clinical Investigation|February 1, 1981
Development of bone mineral loss in insulin-treated diabetes: a 1 1/2 years follow-up study in sixty patientsP McNair, C Christiansen, M S Christensen, et al.
Annals of Neurology|April 1, 1988
Aphasia in senile dementia of the Alzheimer typeK Faber-Langendoen, J C Morris, J W Knesevich, et al.
Diabetologia|November 1, 1979
Bone loss in diabetes: effects of metabolic stateP McNair, S Madsbad, C Christiansen, et al.
Pageof 12